SCHEMBL30458112

SCHEMBL30458112

COC(=O)c1ccc2sc(C(F)(F)F)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.50
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 7/20 0.47
NPC1 O15118 7/20 0.47
RAB9A P51151 7/20 0.47
MAPT P10636 3/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
TNF P01375 2/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 2/20 0.47
MCL1 Q07820 2/20 0.47
NOD1 Q9Y239 2/20 0.47
NR2F2 P24468 1/20 0.47
KLF5 Q13887 1/20 0.47
PIK3CA P42336 1/20 0.47
PIK3CB P42338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25234075 1.00 HTT (0.50) HTTKDM4EALDH1A1LMNAL3MBTL1
SCHEMBL31120903 0.80 NPC1 (0.71) HTTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL2970236 0.80 NPC1 (0.71) HTTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL31398710 0.80 HDAC1 (0.51) HTTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL1121389 0.78 NPC1 (0.50) HTTKDM4EALDH1A1LMNAL3MBTL1
SCHEMBL9305296 0.78 PIK3CA (0.50) HTTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL1121708 0.78 CYP3A4 (0.57) HTTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL18982832 0.78 NPC1 (0.43) HTTKDM4EALDH1A1LMNAL3MBTL1
SCHEMBL2707360 0.76 HDAC6 (0.68) PIK3CAPIK3CBPIK3CGPI4KBHDAC6
SCHEMBL14504404 0.76 RAB9A (0.51) HTTKDM4EALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448500-A1 BENZOTHIAZOLE, BENZOISOXAZOLE AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS Bristol-Myers Squibb Company (US) 2024-10-23 EP disclosed
WO-2023114822-A1 BENZOTHIAZOLE, BENZOISOXAZOLE AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-22 WO disclosed